Impact of cangrelor overdosing on bleeding complications in patients undergoing percutaneous coronary intervention: insights from the CHAMPION trials
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Impact of cangrelor overdosing on bleeding complications in patients undergoing percutaneous coronary intervention: insights from the CHAMPION trials
Authors
Keywords
Antiplatelet, Cangrelor, Overdosing, PCI
Journal
JOURNAL OF THROMBOSIS AND THROMBOLYSIS
Volume 40, Issue 3, Pages 317-322
Publisher
Springer Nature
Online
2015-05-29
DOI
10.1007/s11239-015-1233-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Long-Term Use of Ticagrelor in Patients with Prior Myocardial Infarction
- (2015) Marc P. Bonaca et al. NEW ENGLAND JOURNAL OF MEDICINE
- Adenosine-Mediated Effects of Ticagrelor
- (2014) Marco Cattaneo et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Novel antiplatelet agents in acute coronary syndrome
- (2014) Francesco Franchi et al. Nature Reviews Cardiology
- Association Between Bleeding Events and In-hospital Mortality After Percutaneous Coronary Intervention
- (2013) Adnan K. Chhatriwalla et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Electrocardiographic Safety of Cangrelor, a New Intravenous Antiplatelet Agent
- (2013) Cynthia L. Green et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Effect of cangrelor on periprocedural outcomes in percutaneous coronary interventions: a pooled analysis of patient-level data
- (2013) Philippe Gabriel Steg et al. LANCET
- Effect of Platelet Inhibition with Cangrelor during PCI on Ischemic Events
- (2013) Deepak L. Bhatt et al. NEW ENGLAND JOURNAL OF MEDICINE
- Antithrombotic Therapy in Patients With Chronic Kidney Disease
- (2012) Davide Capodanno et al. CIRCULATION
- A Randomized, Double-Blind, Active-Controlled Phase 2 Trial to Evaluate a Novel Selective and Reversible Intravenous and Oral P2Y 12 Inhibitor Elinogrel Versus Clopidogrel in Patients Undergoing Nonurgent Percutaneous Coronary Intervention
- (2012) Robert C. Welsh et al. Circulation-Cardiovascular Interventions
- Platelet Biology and Response to Antiplatelet Therapy in Women
- (2012) Tracy Y. Wang et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Pharmacodynamic effects of cangrelor and clopidogrel: the platelet function substudy from the cangrelor versus standard therapy to achieve optimal management of platelet inhibition (CHAMPION) trials
- (2012) Dominick J. Angiolillo et al. JOURNAL OF THROMBOSIS AND THROMBOLYSIS
- Bleeding and Acute Coronary Syndromes: Defining, Predicting, and Managing Risk and Outcomes
- (2011) Sharif A. Halim et al. CURRENT DRUG TARGETS
- Antithrombotic Therapy in the Elderly
- (2010) Davide Capodanno et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- The Transradial Approach to Percutaneous Coronary Intervention
- (2010) Sunil V. Rao et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Bleeding associated with current therapies for acute coronary syndrome: What are the mechanisms?
- (2010) Matthew A. Cavender et al. JOURNAL OF THROMBOSIS AND THROMBOLYSIS
- Impact of race and gender on antithrombotic therapy
- (2010) Davide Capodanno et al. THROMBOSIS AND HAEMOSTASIS
- Associations of major bleeding and myocardial infarction with the incidence and timing of mortality in patients presenting with non-ST-elevation acute coronary syndromes: a risk model from the ACUITY trial
- (2009) R. Mehran et al. EUROPEAN HEART JOURNAL
- Intravenous Platelet Blockade with Cangrelor during PCI
- (2009) Deepak L. Bhatt et al. NEW ENGLAND JOURNAL OF MEDICINE
- Platelet Inhibition with Cangrelor in Patients Undergoing PCI
- (2009) Robert A. Harrington et al. NEW ENGLAND JOURNAL OF MEDICINE
- Periprocedural Bleeding and 1-Year Outcome After Percutaneous Coronary Interventions
- (2008) Gjin Ndrepepa et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started